Trial Profile
Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2024
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 16 Apr 2024 Planned End Date changed from 1 Jul 2024 to 1 Jul 2028.
- 16 Apr 2024 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2027.
- 13 Feb 2020 Planned number of patients changed from 2868 to 1434.